Close

Needham & Company Reiterates Buy Rating, $150 Price Target on Sarepta Therapeutics (SRPT) Jul 7, 2022 06:13AM
Sarepta's (SRPT) Clinical Hold Should not Affect Timeline for Development and Approval - Needham & Company Reiterates Buy Rating, $150 PT Jun 24, 2022 06:09AM
Needham & Company Reiterates Buy Rating, $150 Price Target on Sarepta Therapeutics (SRPT), "We Continue to View SRPT as the Industry Leader" May 5, 2022 06:46AM
Sarepta Therapeutics (SRPT) Reiterated at Buy by Needham & Company, Analyst Continues to Believe in Company's Platform and Execution Mar 2, 2022 06:26AM
Sarepta Therapeutics (SRPT) PT Lowered to $150 but Needham & Company Offers 4 Reasons to be Bullish into the 2-Year Update Jan 5, 2022 06:31AM
View Older Stories

Nov 4, 2021 06:41AM Sarepta Therapeutics (SRPT) PT Lowered to $157 at Needham & Company
May 3, 2021 11:58AM Needham & Company Reiterates Buy Rating on Sarepta Therapeutics (SRPT) on Positive 5051 Update
Nov 6, 2020 09:27AM Pre-Open Stock Movers 11/06: (GPRO) (GLUU) (CSLT) Higher; (ASMB) (TRUE) (STMP) Lower (more...)
Aug 12, 2020 07:18AM Companies with NDRs 08/12
Dec 13, 2019 01:08PM Sarepta Therapeutics (SRPT) PT Raised to $182 at Needham & Company
Oct 4, 2019 12:18PM Needham & Company Reiterates Buy Rating on Sarepta Therapeutics (SRPT)
Aug 20, 2019 10:16AM Sarepta Therapeutics (SRPT) PT Lowered to $170 at Needham & Company
May 10, 2019 08:47AM Sarepta Therapeutics (SRPT) Buy Rating Reiterated At Needham After Exondys Sales Guidance Is Maintained
Mar 25, 2019 12:11PM Needham & Company Reiterates Buy Rating on Sarepta Therapeutics (SRPT) Following Update
Sep 21, 2018 09:15AM Sarepta Therapeutics (SRPT) PT Lowered to $196 at Needham & Company
Jun 20, 2018 06:32AM Sarepta Therapeutics (SRPT) PT Raised to $204 at Needham & Company
May 7, 2018 06:20AM Sarepta Therapeutics (SRPT) PT Raised to $109 at Needham & Company
Oct 26, 2017 06:49AM Sarepta Therapeutics (SRPT): Another Beat and Raise for Exondys - Needham
Sep 6, 2017 08:42AM Sarepta Therapeutics (SRPT): Needham & Company Highlights 2 Significant Positive Implications from Dolodiresen Data
Mar 1, 2017 07:44AM Sarepta Therapeutics (SRPT) PT Lowered to $75 at Needham & Company; 'FY17 Guidance Significantly Below Expectations'
Feb 22, 2017 05:39AM Sarepta Therapeutics (SRPT) PT Lowered to $78 at Needham & Company; PRV Sale Closes Funding Gap
Jan 12, 2017 09:00AM Needham & Company Positive on Sarepta (SRPT) Initial Exondys Launch Metrics
Oct 6, 2016 07:54AM Sarepta (SRPT) Bullish View Reiterated at Needham & Company on Expanded European DMD Pipeline
Sep 22, 2016 06:01PM Sarepta Therapeutics (SRPT) Prices 5.02M Shares at $59.75
Sep 22, 2016 06:00PM Sarepta Therapeutics Announces Pricing of $300 Million Public Offering of Common Stock
Sep 19, 2016 01:37PM Sarepta Therapeutic (SRPT) PT Raised to $81 at Needham & Company
Sep 14, 2016 01:54PM Sarepta (SRPT) PT Raised to $47 at Needham & Company; Sees Upside to $60
Jul 22, 2016 09:57AM Sarepta Therapeutics (SRPT) Gains as FDA Update Awaited
Apr 26, 2016 09:29AM Pre-Open Stock Movers 04/26: (KN) (TCS) (PETX) Higher; (CPRX) (SRPT) (WHR) Lower (more...)
Apr 26, 2016 07:23AM Despite Negative FDA Panel, Needham & Company Sees Approval of Sarepta's (SRPT) Eteplirsen as Early as Next Year
Apr 22, 2016 06:40AM Buy Sarepta Therapeutic (SRPT) on Sell-Off - Needham & Company
Apr 6, 2016 09:29AM Pre-Open Stock Movers 04/06: (PLCM) (AYI) (SRPT) Higher; (CREE) (TROX) (MAT) Lower (more...)
Mar 22, 2016 07:25AM Sarepta's (SRPT) Eteplirsen Supported By Key Opinion Leaders - Needham & Company
Nov 25, 2015 12:14PM Streetinsider.com's Hot Lunchtime Reads 11/25: (VRX) (OCN) (SRPT) (MPC)
Nov 25, 2015 12:09PM Needham & Company Remains Confident in Sarepta Therapeutic (SRPT) Approval
Nov 20, 2015 12:16PM Streetinsider.com's Hot Lunchtime Reads 11/20: (TSLA) (GOOG) (EROS) (VTL) (SRPT)
Nov 20, 2015 11:19AM Concerns on Drisapersen Positive for Sarepta's (SRPT) Eteplirsen - Needham & Company
Nov 6, 2015 06:53AM Needham & Company Maintain High Conviction for Sarepta (SRPT) Eteplirsen Approval
Oct 9, 2015 11:19AM Sarepta Therapeutics Announces Closing of $127 Million Public Offering of Common Stock
Oct 6, 2015 09:46AM UPDATE: Sarepta's (SRPT) Prices 3.25M Common Stock Secondary Offering at $39/Share
Oct 6, 2015 09:15AM Sarepta Therapeutics Announces Pricing of $127 Million Public Offering of Common Stock
Oct 1, 2015 02:13PM Sarepta Therapeutic (SRPT) PT Lifted to $55 at Needham & Company
May 7, 2015 12:34PM Streetinsider.com's Hot Lunchtime Reads 5/7: (SZYM) (PRGO) (CLI) (ZU) (SRPT)
May 7, 2015 11:22AM Needham & Company Awaits NDA Filing, Reit Buy on Sarepta Therapeutics (SRPT)
Mar 2, 2015 08:43AM Sarepta Therapeutic (SRPT) PT Cut to $38 at Needham & Company; 'Buy' Maintained
Feb 26, 2015 09:33AM Pre-Open Stock Movers 02/26: (ELX) (CYBX) (UIL) (CRM) Higher; (CLRX) (LKQ) (TASR) Lower (more...)
Nov 24, 2014 09:31AM Pre-Open Stock Movers 11/24: (RNA) (CIMT) (PTP) Higher; (LGF) (TSL) (CBI) Lower (more...)
Nov 6, 2014 12:18PM Streetinsider.com's Hot Lunchtime Reads 11/6: (LCI) (TSLA) (STMP) (SRPT)
Nov 6, 2014 11:35AM Needham & Company Maintains Bullish View on Sarepta Therapeutic (SRPT) Following Results and Eteplirsen Regulatory Update
Oct 27, 2014 10:07AM Sarepta Therapeutic (SRPT) Story Remains Intact, Needham & Company Says
Oct 1, 2014 09:33AM Pre-Open Stock Movers 10/01: (TKMR) (HEB) (ANGI) Higher; (FNMA) (FMCC) (WPRT) Lower (more...)
Aug 7, 2014 12:15PM Streetinsider.com's Hot Lunchtime Reads 08/07: (TWX) (HIMX) (SRPT) (AAPL)
Aug 7, 2014 11:55AM Sarepta Therapeutic (SRPT) Eteplirsen NDA Filing on Track for Year-End, Needham & Company
Jul 11, 2014 07:34AM Needham & Company Takes a Closer Look at 144 Week Data for Sarepta's (SRPT) Eteplirsen
Jul 10, 2014 11:07AM Sarepta Therapeutic (SRPT) Sell-Off on Confusing WSJ Article 'Unjustified'; Eteplirsen Timelines Intact
View Older Stories